Hsien-yi Wang - Publications

Sepsis and Infectious Outcomes for GLP-r Agonists in CKD plus Type 2 Diabetes.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 07, 2026

Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: March 26, 2026

Impact of prior COVID-19 vaccination on major adverse kidney events in patients with non-dialysis dependent chronic kidney disease: a global retrospective study.

Journal: Expert review of vaccines

Published: July 20, 2025

Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk.

Journal: Cancer immunology, immunotherapy : CII

Published: February 27, 2025

Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 28, 2025